drugset / Trial / NCT01613092

Prevention of Arrhythmia Device Infection Trial (PADIT)

NCT01613092 ↗

Phase 4 Completed 241 enrolled Population Health Research Institute
RandomizedCrossoverOpen-labelPrevention

Summary

The goal of the pilot study is to compare whether a centre-wide policy of incremental antibiotic therapy will reduce pacemaker infection compared to a policy of conventional antibiotic prophylaxis in high-risk patients undergoing arrhythmia device procedures. This pilot study will provide feasibility information for a larger cluster randomized crossover design (CRCD).

Timeline

Start
2011-05
Primary completion
2013-11
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bacitracin Unknown — —
Comparator CEPHALEXIN ANHYDROUS Small molecule — —
Comparator Clindamycin Unknown — —
Comparator Vancomycin Other / unclassified — —
Background Cefazolin Small molecule — —